PAPP-A-Specific IGFBP-4 Proteolysis in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Authors:
- Daria A. AdashevaDADaria A. Adasheva
- Olga S. LebedevaOLOlga S. Lebedeva
- Daria V. GoliusovaDGDaria V. Goliusova
- Alexander B. PostnikovAPAlexander B. Postnikov
- Maria V. TeriakovaMTMaria V. Teriakova
- Irina V. KopylovaIKIrina V. Kopylova
- Maria A. LagarkovaMLMaria A. Lagarkova
- Alexey G. KatrukhaAKAlexey G. Katrukha
- Daria V. SerebryanayaDSDaria V. Serebryanaya
Open Access
- 8 May 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (9) , 8420
Abstract
The insulin-like growth factors IGF-I and IGF-II—as well as their binding proteins (IGFBPs), which regulate their bioavailability—are involved in many pathological and physiological processes in cardiac tissue. Pregnancy-associated plasma protein A (PAPP-A) is a metalloprotease that preferentially cleaves IGFBP-4, releasing IGF and activating its biological activity. Previous studies have shown that PAPP-A-specific IGFBP-4 proteolysis is involved in the pathogenesis of cardiovascular diseases, such as ischemia, heart failure, and acute coronary syndrome. However, it remains unclear whether PAPP-A-specific IGFBP-4 proteolysis participates in human normal cardiomyocytes. Here, we report PAPP-A-specific IGFBP-4 proteolysis occurring in human cardiomyocytes derived from two independent induced pluripotent cell lines (hiPSC-CMs), detected both on the cell surface and in the cell secretome. PAPP-A was measured by fluoroimmune analysis (FIA) in a conditioned medium of hiPSC-CMs and was detected in concentrations of up to 4.3 ± 1.33 ng/mL and 3.8 ± 1.1 ng/mL. The level of PAPP-A-specific IGFBP-4 proteolysis was determined as the concentration of NT-IGFBP-4 proteolytic fragments using FIA for a proteolytic neo-epitope-specific assay. We showed that PAPP-A-specific IGFBP-4 proteolysis is IGF-dependent and inhibited by EDTA and 1,10-phenanthroline. Therefore, it may be concluded that PAPP-A-specific IGFBP-4 proteolysis functions in human normal cardiomyocytes, and hiPSC-CMs contain membrane-bound and secreted forms of proteolytically active PAPP-A.Keywords
Funding Information
- State Foundation (O5-1-21, 19-29-04113\21)
- RFBR (O5-1-21, 19-29-04113\21)
This publication has 47 references indexed in Scilit:
- Identification and Characterization of Calcium Sparks in Cardiomyocytes Derived from Human Induced Pluripotent Stem CellsPLOS ONE, 2013
- Differential regulation of pregnancy associated plasma protein-A in human coronary artery endothelial cells and smooth muscle cellsGrowth Hormone & IGF Research, 2008
- Cytokine stimulation of pregnancy-associated plasma protein A expression in human coronary artery smooth muscle cells: inhibition by resveratrolAmerican Journal of Physiology-Cell Physiology, 2006
- Molecular Distinction of Circulating Pregnancy-Associated Plasma Protein A in Myocardial Infarction and PregnancyClinical Chemistry, 2005
- Complex of Pregnancy-associated Plasma Protein-A and the Proform of Eosinophil Major Basic ProteinJournal of Biological Chemistry, 2003
- Cell Surface Targeting of Pregnancy-associated Plasma Protein A Proteolytic ActivityJournal of Biological Chemistry, 2002
- Substrate specificity of the metalloproteinase pregnancy-associated plasma protein-A (PAPP-A) assessed by mutagenesis and analysis of synthetic peptides: substrate residues distant from the scissile bond are critical for proteolysisBiochemical Journal, 2002
- Pregnancy-Associated Plasma Protein A as a Marker of Acute Coronary SyndromesNew England Journal of Medicine, 2001
- Proteolytic Activity Degrading Insulin-like Growth Factor-Binding Protein−2, −3, −4, and −5 in Healthy Growing and Atretic Follicles in the Pig Ovary1Biology of Reproduction, 1997
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976